Descripción

Nav1.1 through Nav1.6 channel subtype expression in cortical neurons. Mutations in SCN1A (Nav1.1) cause Dravet syndrome, the epilepsy subtype most responsive to cannabidiol treatment.

Figure 207

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 207: Nav1.1 through Nav1.6 channel subtype expression in cortical neurons. Mutations in SCN1A (Nav1.1) cause Dravet syndrome, the epilepsy subtype most responsive to cannabidiol treatment.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Nav1.1 through Nav1.6 channel subtype expression in cortical neurons. Mutations in SCN1A (Nav1.1) cause Dravet syndrome, the epilepsy subtype most responsive to cannabidiol treatment." />
  <figcaption>Figure 207. Nav1.1 through Nav1.6 channel subtype expression in cortical neurons. Mutations in SCN1A (Nav1.1) cause Dravet syndrome, the epilepsy subtype most responsive to cannabidiol treatment.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Evidencia relacionada

CBD para Insomnio

Calificación A · 103 estudios